Perspectives in Rheumatic Diseases

September 8, 2022 – September 10, 2022

The Venetian® Las Vegas

Hybrid

swoosh
swoosh

ACCREDITATION

TARGET AUDIENCE

This conference is designed for rheumatologists, family practice physicians, internists, nurse practitioners, nurses, physician assistants, and pharmacists.

 

LEARNING OBJECTIVES

After completing this activity, the participant should be better able to: [LIST][ITEM] Assess current and emerging immunosuppressive, anti-inflammatory, and disease-modifying treatments for rheumatic diseases considering pathophysiologic targets; mechanisms of action; safety and efficacy data; dosing, adherence and access; and impact on therapeutic selection [ITEM]Describe evidence-based guidance for mitigating complications associated with rheumatic diseases [ITEM]Evaluate treatment options for the management of rheumatic manifestations of autoimmune diseases and atypical manifestations of rheumatic diseases [ITEM]Apply current guideline recommendations and shared decision-making strategies that improve the management of patients with rheumatic diseases, especially in the context of the COVID-19 pandemic[/LIST]

 

ACCREDITATION STATEMENTS

 

 

[BOLD]POSTGRADUATE INSTITUTE FOR MEDICINE (PIM) AND GLOBAL ACADEMY FOR MEDICAL EDUCATION[/BOLD] [JALOGO] In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine (PIM) and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [bold]Physician Continuing Medical Education [/bold] The Postgraduate Institute for Medicine designates this live activity for a maximum of 16.5 [italic]AMA PRA Category 1 Credits™. [/italic] [bold]Continuing Nursing Education [/bold] The maximum number of hours awarded for this Continuing Nursing Education activity is 16.5 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on certificates. [bold]California Board of Registered Nursing[/bold] Provider approved by the California Board of Registered Nursing, Provider Number 13485, for 16.5 contact hours. [ABIMMOC] Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 16.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. [ABOPMOC] Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 16.5 MOC points in the American Board of Pediatric’ s (ABP) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit. [bold]AAFP Credit[/bold] The AAFP has reviewed 15th Annual Perspectives in Rheumatic Diseases Virtual CME/CE Conference and deemed it acceptable for up to 17.75 Live AAFP Prescribed credits. Term of Approval is from 09/08/2022 to 09/10/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Please note that the following topic was denied AAFP credit. Session IX, Hand Surgery Update, presented by Neal L. Millar, PhD, FRCSEd